Keertan Dheda
Keertan Dheda
Professor of Respiratory Medicine, University of Cape Town
Verified email at - Homepage
Cited by
Cited by
Real-time RT-PCR normalisation; strategies and considerations
J Huggett, K Dheda, S Bustin, A Zumla
Genes & Immunity 6 (4), 279-284, 2005
Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis
NR Gandhi, P Nunn, K Dheda, HS Schaaf, M Zignol, D Van Soolingen, ...
The Lancet 375 (9728), 1830-1843, 2010
Validation of housekeeping genes for normalizing RNA expression in real-time PCR
K Dheda, JF Huggett, SA Bustin, MA Johnson, G Rook, A Zumla
Biotechniques 37 (1), 112-119, 2004
The implications of using an inappropriate reference gene for real-time reverse transcription PCR data normalization
K Dheda, JF Huggett, JS Chang, LU Kim, SA Bustin, MA Johnson, ...
Analytical biochemistry 344 (1), 141-143, 2005
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis
M Sester, G Sotgiu, C Lange, C Giehl, E Girardi, GB Migliori, A Bossink, ...
European Respiratory Journal 37 (1), 100-111, 2011
Gamma interferon release assays for detection of Mycobacterium tuberculosis infection
M Pai, CM Denkinger, SV Kik, MX Rangaka, A Zwerling, O Oxlade, ...
Clinical microbiology reviews 27 (1), 3-20, 2014
Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial
G Theron, L Zijenah, D Chanda, P Clowes, A Rachow, M Lesosky, W Bara, ...
The Lancet 383 (9915), 424-435, 2014
New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis
M Pai, S Kalantri, K Dheda
Expert review of molecular diagnostics 6 (3), 413-422, 2006
The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
K Dheda, T Gumbo, G Maartens, KE Dooley, R McNerney, M Murray, ...
The lancet Respiratory medicine 5 (4), 291-360, 2017
Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting
G Theron, J Peter, R van Zyl-Smit, H Mishra, E Streicher, S Murray, ...
American journal of respiratory and critical care medicine 184 (1), 132-140, 2011
Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load
CL Day, DA Abrahams, L Lerumo, EJ van Rensburg, L Stone, T O’rie, ...
The Journal of Immunology 187 (5), 2222-2232, 2011
Supervised and unsupervised self-testing for HIV in high-and low-risk populations: a systematic review
NP Pai, J Sharma, S Shivkumar, S Pillay, C Vadnais, L Joseph, K Dheda, ...
PLoS Med 10 (4), e1001414, 2013
Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy
K Dheda, FC Lampe, MA Johnson, MC Lipman
Journal of Infectious Diseases 190 (9), 1670-1676, 2004
Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study
K Dheda, K Shean, A Zumla, M Badri, EM Streicher, L Page-Shipp, ...
The Lancet 375 (9728), 1798-1807, 2010
Lung remodeling in pulmonary tuberculosis
K Dheda, H Booth, JF Huggett, MA Johnson, A Zumla, GAW Rook
The Journal of infectious diseases 192 (7), 1201-1210, 2005
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD
RN van Zyl Smit, M Pai, WW Yew, CC Leung, A Zumla, ED Bateman, ...
European respiratory journal 35 (1), 27-33, 2010
New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance
M Pai, S Kalantri, K Dheda
Expert review of molecular diagnostics 6 (3), 423-432, 2006
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
K Dheda, T Gumbo, NR Gandhi, M Murray, G Theron, Z Udwadia, ...
The lancet Respiratory medicine 2 (4), 321-338, 2014
Immune responses to tuberculosis in developing countries: implications for new vaccines
GAW Rook, K Dheda, A Zumla
Nature Reviews Immunology 5 (8), 661-667, 2005
Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study
E Pietersen, E Ignatius, EM Streicher, B Mastrapa, X Padanilam, A Pooran, ...
The Lancet 383 (9924), 1230-1239, 2014
The system can't perform the operation now. Try again later.
Articles 1–20